Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Targeted Cancer Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Targeted Cancer Drugsmarket, defines the market attractiveness level of Targeted Cancer Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Targeted Cancer Drugs industry, describes the types of Targeted Cancer Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Targeted Cancer Drugs market and the development prospects and opportunities of Targeted Cancer Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Targeted Cancer Drugs market in Chapter 13.
By Player:
Eli Lilly
Galapagos
Teva
Vertex
Sanofi
Incyte
Celgene
Astellas Pharma
Gilead
AbbVie
Novartis
Pfizer
By Type:
Cancer Growth Blocker Drug
Monoclonal Antibody
Other
By End-User:
Hospitals
Academic & Research Institutes
Diagnostic & Reference Laboratories
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Targeted Cancer Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Targeted Cancer Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Targeted Cancer Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Targeted Cancer Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Targeted Cancer Drugs Market Analysis and Outlook to 2022
-
7.1 Global Targeted Cancer Drugs Consumption (2017-2022)
-
7.2 United States Targeted Cancer Drugs Consumption (2017-2022)
-
7.3 Europe Targeted Cancer Drugs Consumption (2017-2022)
-
7.4 China Targeted Cancer Drugs Consumption (2017-2022)
-
7.5 Japan Targeted Cancer Drugs Consumption (2017-2022)
-
7.6 India Targeted Cancer Drugs Consumption (2017-2022)
-
7.7 South Korea Targeted Cancer Drugs Consumption (2017-2022)
8 Region and Country-wise Targeted Cancer Drugs Market Analysis and Outlook to 2028
-
8.1 Global Targeted Cancer Drugs Consumption Forecast (2022-2028)
-
8.2 United States Targeted Cancer Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Targeted Cancer Drugs Consumption Forecast (2022-2028)
-
8.4 China Targeted Cancer Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Targeted Cancer Drugs Consumption Forecast (2022-2028)
-
8.6 India Targeted Cancer Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Targeted Cancer Drugs Consumption Forecast (2022-2028)
9 Global Targeted Cancer Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Targeted Cancer Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Cancer Growth Blocker Drug Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Monoclonal Antibody Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Targeted Cancer Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Academic & Research Institutes Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Diagnostic & Reference Laboratories Consumption and Growth Rate (2017-2022)
10 Global Targeted Cancer Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Targeted Cancer Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Cancer Growth Blocker Drug Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Monoclonal Antibody Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Targeted Cancer Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Academic & Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Diagnostic & Reference Laboratories Consumption Forecast and Growth Rate (2022-2028)
11 Global Targeted Cancer Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Targeted Cancer Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Targeted Cancer Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Targeted Cancer Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Targeted Cancer Drugs Market Competitive Analysis
-
14.1 Eli Lilly
-
14.1.1 Eli Lilly Company Details
-
14.1.2 Eli Lilly Targeted Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Eli Lilly Targeted Cancer Drugs Product and Service
-
14.2 Galapagos
-
14.2.1 Galapagos Company Details
-
14.2.2 Galapagos Targeted Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Galapagos Targeted Cancer Drugs Product and Service
-
14.3 Teva
-
14.3.1 Teva Company Details
-
14.3.2 Teva Targeted Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Teva Targeted Cancer Drugs Product and Service
-
14.4 Vertex
-
14.4.1 Vertex Company Details
-
14.4.2 Vertex Targeted Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Vertex Targeted Cancer Drugs Product and Service
-
14.5 Sanofi
-
14.5.1 Sanofi Company Details
-
14.5.2 Sanofi Targeted Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Sanofi Targeted Cancer Drugs Product and Service
-
14.6 Incyte
-
14.6.1 Incyte Company Details
-
14.6.2 Incyte Targeted Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Incyte Targeted Cancer Drugs Product and Service
-
14.7 Celgene
-
14.7.1 Celgene Company Details
-
14.7.2 Celgene Targeted Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Celgene Targeted Cancer Drugs Product and Service
-
14.8 Astellas Pharma
-
14.8.1 Astellas Pharma Company Details
-
14.8.2 Astellas Pharma Targeted Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Astellas Pharma Targeted Cancer Drugs Product and Service
-
14.9 Gilead
-
14.9.1 Gilead Company Details
-
14.9.2 Gilead Targeted Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Gilead Targeted Cancer Drugs Product and Service
-
14.10 AbbVie
-
14.10.1 AbbVie Company Details
-
14.10.2 AbbVie Targeted Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 AbbVie Targeted Cancer Drugs Product and Service
-
14.11 Novartis
-
14.11.1 Novartis Company Details
-
14.11.2 Novartis Targeted Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Novartis Targeted Cancer Drugs Product and Service
-
14.12 Pfizer
-
14.12.1 Pfizer Company Details
-
14.12.2 Pfizer Targeted Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Pfizer Targeted Cancer Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Targeted Cancer Drugs
-
Figure Targeted Cancer Drugs Picture
-
Table Global Targeted Cancer Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Targeted Cancer Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Targeted Cancer Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Targeted Cancer Drugs Consumption by Country (2017-2022)
-
Figure United States Targeted Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Targeted Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Targeted Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Targeted Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Targeted Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Targeted Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Targeted Cancer Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Targeted Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Targeted Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Targeted Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Targeted Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Targeted Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Targeted Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Growth Blocker Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Monoclonal Antibody Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Academic & Research Institutes Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnostic & Reference Laboratories Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Growth Blocker Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Monoclonal Antibody Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Academic & Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnostic & Reference Laboratories Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Targeted Cancer Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Targeted Cancer Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Targeted Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Targeted Cancer Drugs Product and Service
-
Table Galapagos (Foundation Year, Company Profile and etc.)
-
Table Galapagos Targeted Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Galapagos Targeted Cancer Drugs Product and Service
-
Table Teva (Foundation Year, Company Profile and etc.)
-
Table Teva Targeted Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Targeted Cancer Drugs Product and Service
-
Table Vertex (Foundation Year, Company Profile and etc.)
-
Table Vertex Targeted Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vertex Targeted Cancer Drugs Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Targeted Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Targeted Cancer Drugs Product and Service
-
Table Incyte (Foundation Year, Company Profile and etc.)
-
Table Incyte Targeted Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Incyte Targeted Cancer Drugs Product and Service
-
Table Celgene (Foundation Year, Company Profile and etc.)
-
Table Celgene Targeted Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Targeted Cancer Drugs Product and Service
-
Table Astellas Pharma (Foundation Year, Company Profile and etc.)
-
Table Astellas Pharma Targeted Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma Targeted Cancer Drugs Product and Service
-
Table Gilead (Foundation Year, Company Profile and etc.)
-
Table Gilead Targeted Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Targeted Cancer Drugs Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Targeted Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Targeted Cancer Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Targeted Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Targeted Cancer Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Targeted Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Targeted Cancer Drugs Product and Service
-
